New Perspectives on Antimicrobial Agents: Cefiderocol-Reference-Cited by-同舟云学术

New Perspectives on Antimicrobial Agents: Cefiderocol

Published:2021-07-16 Issue:8 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

McCreary Erin K.¹^ORCID,Heil Emily L.²,Tamma Pranita D.³^ORCID

Affiliation:

1. Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

2. Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA

3. Department of Pediatrics, Division of Pediatric Infectious Diseases, Baltimore, Maryland, USA

Abstract

Bacterial resistance to carbapenem agents has reached alarming levels. Accordingly, collaborative efforts between national and international organizations and the pharmaceutical industry have led to an impressive expansion of commercially available β-lactam agents in recent years.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.02171-20

Reference104 articles.

1. The Infectious Diseases Society of America’s 10 × ’20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × ’20 a Possibility?

2. In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

3. The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics

4. Present and Future of Siderophore-Based Therapeutic and Diagnostic Approaches in Infectious Diseases

5. Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gramnegative Erreger (3MRGN/4MRGN): Häufigkeit und Besonderheiten;DMW - Deutsche Medizinische Wochenschrift;2024-09

2. Efflux pump-mediated resistance to new beta lactam antibiotics in multidrug-resistant gram-negative bacteria;Communications Medicine;2024-08-29

3. Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria;Cells;2024-08-06

4. Structure–Activity Relationship of Pyrrolidine Pentamine Derivatives as Inhibitors of the Aminoglycoside 6′-N-Acetyltransferase Type Ib;Antibiotics;2024-07-19

5. In-vitro approaches for cefiderocol susceptibility testing and interpretation in the context of recent Clinical & Laboratory Standards Institute advisory;Indian Journal of Medical Microbiology;2024-07